BELHYPERION
ActiveSummary
BELHYPERION has been active since 2006 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.43bn and a net result of €166.1m. Equity is growing by about 5.5% per year across the filed financial years. Its solvency ranks better than 66% of 3,853 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Directors
Board 4
Day-to-day management 2
Permanent representatives 1
Statutory auditor 1
Not every act has been read: a resignation may still be missing
Mandate history
- Board
- Day-to-day management
- Statutory auditor
- began earlier
| Name | Functions and periods |
|---|---|
| Christian Baillet |
|
| William Buros |
|
| SP Investissement |
|
| Lieven Jacobs |
|
| Forvis Mazars Réviseurs d’Entreprises |
|
| Hervé Le Lous |
|
| BTG Industries et Santé |
|
| Ronan BLANCHARD |
|
Owners and capital
Owners
2 ownersChain of control
- BTG Industries & SantéFR
- BTG INDUSTRIES ET SANTE SAS (à date d'Assemblée Générale)FR
- BELHYPERION
Highest known parent: BTG Industries & Santé (France). The sources do not say who stands above it.
Owners 2
- BTG INDUSTRIES ET SANTE SAS (à date d'Assemblée Générale)FRparentSourceown accounts 2025100%
- BTG Industries & SantéFRconsolidating parentconsolidates
According to the 2025 annual accounts of BELHYPERION and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Capital and shareholders
- 30-11-2022 Capital stated in the deed · €613,926,180.58 · 784,990,126 shares